雜志介紹

Endocrine雜志介紹

《Endocrine》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱內(nèi)分泌，本刊主要出版、報道醫(yī)學(xué)-ENDOCRINOLOGY & METABOLISM領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為3，最新CiteScore 指數(shù)為6.5。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Machine learning-based prediction of diagnostic markers for Graves' orbitopathy

  Author: Cai, Yunying; Su, Heng; Si, Yongting; Ni, Ninghua

• Effects of TSH suppressive therapy on bone mineral density (BMD) and bone turnover markers (BTMs) in patients with differentiated thyroid cancer in Northeast China: a prospective controlled cohort study

  Author: Wang, Shiwei; Wang, Yu; Zhu, Li; He, Liang; Lv, Mutian; Zhang, Hao; Wang, Haoyu; Zhang, Fan; Lai, Yaxin; Li, Yushu; Shan, Zhongyan; Teng, Weiping

• Mutation screening of eight genes and comparison of the clinical data in a Chinese cohort with congenital hypothyroidism

  Author: Li, Liangshan; Li, Xiaole; Wang, Xiaoyu; Han, Mengmeng; Zhao, Dehua; Wang, Fang; Liu, Shiguo

• 2021 Asia-Pacific Graves' Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves' Disease

  Author: Parameswaran, Rajeev; de Jong, Mechteld Christine; Kit, James Lee Wai; Sek, Kathleen; Tran Quang Nam; Tran Viet Thang; Nguyen Thy Khue; Than Than Aye; Phone Myint Tun; Cole, Timothy; Miller, Julie A.; Villa, Michael; Khiewvan, Benjapa; Sirinvaravong, Sirinart; Sin, Yong Lit; Muhammad, Rohaizak; Jap, Tjin Shing; Agrawal, Amit; Rajput, Rajesh; Fernando, Ranil; Sumanatilleke, Manilka; Suastika, Ketut; Shong, Young Kee; Lang, Brian; Bartalena, Luigi; Yang, Samantha Peiling

英文介紹

Endocrine雜志英文介紹

Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.

Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.

Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.